Introduction
The dissociation of the responses to oestrogen into separate groups of responses that can be selectively stimulated, inhibited or completely blocked has suggested the existence of multiple and independent mechanisms of oestrogen action in the rat uterus (Tchernitchin, 1983) . The first group of responses (oestrogen-induced increases in RNA and protein synthesis, the increase in the content of some specific enzymes and biochemical, morphological and functional differentiation of target cells) are believed to be mediated by the cytosolic-nuclear oestrogen receptor system through hormone-receptor interactions with the genome (Jensen & De Sombre, 1972) . These responses can be blocked by actinomycin D (Ui & Mueller, 1963; Hamilton, 1964; Means & Hamilton, 1966; Tchernitchin & Galand, 1982) ; therefore, they can be considered as the genomic responses to oestrogen stimulation (Tchernitchin & Galand, 1982) . The second group of responses (e.g. uterine eosinophilia, oedema, increase in vascular permeability, release of histamine) is independent of uterine genome (Tchernitchin & Galand, 1982) and may be mediated by the uterine eosinophil leucocytes (Tchernitchin, 1972 (Tchernitchin, , 1979 (Tchernitchin, , 1983 . Tchernitchin & Galand (1982) suggest that the eosinophils migrate from the blood to the uterus by a non-genomic mechanism which is dependent on oestrogen levels in the blood but not in the uterus (Tchernitchin & Galand, 1983) and is possibly mediated by oestrogen receptors in the eosinophils (Tchernitchin & Tchernitchin, 1976; Tchernitchin, 1983) . It was suggested that the eosinophils release into the uterine stroma various agents and enzymes that may play a role in oestrogen action (Tchernitchin, 1983) . The (Jellinck, Affleck & Newcombe, 1983 ). Since it is accepted that virtually all of the oestrogen-induced increase in peroxidase content in the uterus corresponds to the enzyme carried by the eosinophils migrating from the blood to the uterus, and only a minor amount corresponds to the endogenous peroxidase synthesized by uterine cells (King, Allen & De Sombre, 1981) , it seemed likely that the reported effect of testosterone should correspond to a blockage of oestrogen-induced migration of eosinophils to the uterus. To check for this possibility and to investigate the mechanisms involved in this interaction, we studied the effects of a short-term testosterone treatment on oestrogen-induced accumulation of eosinophils in the uterus and on blood eosinophil levels and degranulation in vivo and in vitro. Considering that any condition interfering with eosinophil migration to the uterus should modify the oestrogenic responses dependent on eosinophils, we also investigated oestrogen-induced uterine oedema (water imbibition).
Materials and Methods
Hormones. OestradiolT7ß (Sigma, St Louis, MO, U.S.A.) was dissolved in absolute ethanol (500 pg/ml) and was diluted 1 :9 in saline (9 g NaCl/1) immediately before injection. Testosterone propionate (Merck, Darmstadt, West The following responses to oestrogen stimulation in the uterus were studied : (a) uterine wet weight, (b) total number of eosinophils in the uterus including the mesometrium, (c) total number of eosinophils located in uterine endometrium plus myometrium, and (d) oedema in the deep endometrial stroma, measured as the increase in the reciprocal value of cell density (RVCD) in deep endometrium. Since the different tissues of the uterine horns may reflect different characteristics, uterine eosinophil quantification and deep endometrial cell density evaluation were performed in several uterine cross-sections obtained at various levels of the organ.
The eosinophils were counted and classified according to their distribution within the different histological layers of the uterus (endometrium, myometrium and mesometrium). The total number of eosinophils in the uterus or in endometrium plus myometrium only was estimated by multiplying the average number of eosinophils per uterine cross-section by a previously calculated appropriate factor (300) which takes into account the thickness of the section, and by the total length of the fixed uterine horn expressed in mm (Tchernitchin, Roorijck, Tchernitchin, Vandenhende & Galand, 1974) .
The cell density quantification was performed in several areas chosen at random in the deep endometrial stroma. The number of cell nuclei was determined in a standard area of 707 pm2 by a circle marked in the ocular piece of the microscope (at 1000). The reciprocal number of the value obtained for cell density (RVCD) was calculated by dividing the area in which cells were counted by the number of cells in that area; this value corresponds to the intracellular plus adjacent extracellular area related to one cell, and its increase reflects the oestrogen-induced oedematous reaction of deep endometrium (water imbibition) (Grunert & Tchernitchin, 1982) .
The oestrogen-induced increases in uterine wet weight and in deep endometrial RVCD were expressed as a percentage of the control value ; uterine eosinophilia was expressed in total numbers. Effect of testosterone propionate on blood eosinophils. Adult female Sprague-Dawley rats, 230-310 g body weight, were ovariectomized 10 days before the experiment. The animals were injected with testosterone propionate (50 mg/kg) or the vehicle. The injection was done under ether anaesthesia into the jugular vein. The blood samples were obtained under ether anaesthesia from the tail of each rat before testosterone propionate or vehicle injection and 6 h after treatment.
The blood samples were collected in small glass vials containing a 5% (w/v) EDTA solution in distilled water (blood : EDTA dilution 9:1, v/v) and incubated for 60 min at 18°C. Aliquants were taken immediately after blood sample collection, at 30 and at 60 min of incubation for a dilution 1:10 (v/v) with freshly prepared eosin stain solution (1 ml 1% eosin yellow stock solution in absolute ethanol diluted in 19 ml distilled water and 1 ml acetone) and subsequent quantification in a Neubauer chamber. The eosinophils were counted and classified as degranulated or nondegranulated according to their histological characteristics (Arroyo, Barrera, Grunert, Reyes & Tchernitchin, 1983) . Degranulated eosinophils were those that appeared with a marked decrease in the number of eosin-stained cytoplasmic granules or that had lost almost all granules.
The changes in blood eosinophil levels 6 h after treatment were expressed, for each rat, as a percentage of the values before treatment. The increase in eosinophil degranulation 6 h after treatment was expressed, for each rat, as an increase in the degranulation percentage (measured at the time of blood sample collection) over the values before treatment. Because under some conditions (e.g. 6 h after hormone treatment) there was an increased percentage of degranulated eosinophils at the time of blood sample collection, the in-vitro eosinophil degranulation had to be evaluated by considering the eosinophils that were not degranulated at the time of blood sample collection only; the values of eosinophil degranulation in vitro were expressed as the additional eosinophil degranulation in vitro (Arroyo et ai, 1983) excluding the mesometrium) and in the deep endometrial RVCD (interpreted as oedema) 6 h after its administration. Treatment with testosterone propionate alone (50 mg/kg) did not significantly modify any of these values 6 h after its administration. Testosterone propionate, administered together with oestradiol, inhibited, but not completely, the oestrogen-induced accumulation of eosinophils in the uterus (including its mesometrium), the uterine wet weight increase and the deep endometrial oedema, 6 h after treatment, and almost completely blocked the oestrogen-induced increase in the number of endometrial plus myometrial eosinophils. Effect of testosterone propionate on blood eosinophils Table 2 shows that treatment of adult ovariectomized rats with testosterone propionate (50 mg/kg) resulted in a decrease in the number of eosinophils in the blood and an increase in the degranulation percentage of the eosinophils in vivo, 6 h after treatment. The rate of eosinophil degranulation in vitro, measured as the additional degranulation percentage in vitro at 30 and 60 min of incubation (the degranulation percentage of those eosinophils that were not degranulated at the time of blood sample collection), was also increased 6 h after treatment of the rats with the androgen. 
Discussion
The results show that testosterone propionate, given with oestradiol to immature rats, inhibits the oestrogen-induced uterine eosinophilia and two responses to oestrogen that have been suggested (Tchernitchin, 1972 (Tchernitchin, , 1979 (Tchernitchin, , 1983 to be mediated by eosinophils: the increase in uterine wet weight and the deep endometrial oedematous response, 6 h after hormone treatment. The dose of androgen used in the present study is in the range of the doses shown by Jellinck et ai (1983) to block selectively the oestrogen-induced increase in uterine peroxidase content without interfering with the oestrogen-induced increase in glucose 6-phosphate dehydrogenase activity, the depletion of the oestrogen receptors from the uterine cytosol and oestrogen receptor accumulation in the nucleus. Considering the previous reports that virtually all oestrogen-induced uterine peroxidase corresponds to the enzyme carried by the eosinophils from the blood to the uterus (King et ai, 1981) , we suggest that our findings confirm the possibility that the interference by testosterone with the increase in uterine peroxidase is due to a blockage of eosinophil migration from the blood to the uterus.
The lack of interaction by testosterone with the cytosolic or nuclear oestrogen receptors reported by Jellinck et ai (1983) is not in agreement with previous reports of a weak binding of testosterone by the cytosolic oestrogen receptors , of a testosteroneinduced translocation of the cytosolic oestrogen receptors to the nucleus (Rochefort, Lignon & Capony, 1972) and of an inhibition by testosterone of the cytosolic oestrogen receptor replenishment (Bhakoo & Katzenellenbogen, 1977) . The results reported by Jellinck et ai (1983) may be possibly explained by the increased dissociation of the weakly bound testosterone from the oestrogen receptors (Rochefort, Capony & Garcia, 1979 ) that would favour, in the presence of the high doses of oestrogen used, the formation of oestradiol-oestrogen receptor complexes. However, independently from the way of interaction of testosterone with the cytosolic-nuclear oestrogen receptors, the dissociation by testosterone of the different oestrogenic responses ) and the selective action of testosterone upon some uterine cell types but not others (GonzalezDidi, Komisaruk & Beyer, 1972; Yudaev & Pokrovskij, 1972) suggest that testosterone may selectively interfere with one of the mechanisms of oestrogen action and that there may exist differences amongst cytosolic-nuclear oestrogen receptors in the different uterine cell-types. In this context, the present findings confirm the dissociation of oestrogen-induced uterine eosinophilia and oedema from other responses to oestrogen in the absence of any measurable effect upon cytosolic or nuclear oestrogen receptors, support the idea that uterine eosinophilia and oedema are oestrogenic responses regulated by mechanisms different from those of the genomic responses, and are in agreement with the hypothesis of the mediation of uterine oedema by eosinophils.
It has been previously shown that any eosinopenic condition, such as treatment with glucocorticoids (Tchernitchin, Rooryck, Tchernitchin, Vandenhende & Galand, 1975) , insulin (Steinsapir, Rojas, Alarcón & Tchernitchin, 1982a) or thyroid hormones (Steinsapir, Rojas, Mena & Tchernitchin, 1982b) , that would limit eosinophil availability for migration to the uterus, inhibit eosinophil accumulation in the uterus after oestrogen administration and depress the responses that have been proposed as being mediated by the eosinophils. Our finding of a decrease in the number of eosinophils in the blood by the androgen may explain the limitation of eosinophil migration to the uterus and the selective blockage of the eosinophil-mediated responses. Further, the increased eosinophil degranulation in vivo and in vitro, which would leave smaller amounts of enzymes in the migrating eosinophils, would explain the counteraction by testosterone of the increase in uterine peroxidase (Jellinck et ai, 1983) and of the eosinophil-mediated responses (present results). reported that the antiandrogen flutamide abolishes the inhibitory action of testosterone on uterine peroxidase, and suggested that the inhibitory effect is mediated by specific androgen receptors. To corroborate the mediation of this effect by specific androgen receptors it is necessary to confirm the development of blood eosinopenia at lower doses of testosterone. Although it is not clear whether the eosinopenia and the resulting antioestrogenic effect of the androgen is mediated directly by testosterone or indirectly via hypersécrétion of another hormone, it is possible to speculate that the target organ for this inhibitory action of the androgen is not the uterus. Further studies are necessary to elucidate the mechanisms involved in the eosinopenic action of high doses of testosterone and to identify the target organ(s) or cell-types for this action of the androgen.
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